Trials in progress: a global phase 1/1b clinical trial evaluating exarafenib (KIN-2787), a highly selective pan-RAF inhibitor, in adult patients with BRAF-altered solid tumors and NRAS mutant melanoma

Alexander Spira, Valentina Gambardella, Shumei Kato, Cesar Batista Perez, Meredith Mckean, Maria Gonzalez Cao, Richard Kim, Chris T. Chen, Antoine Italiano,Philippe Cassier, Janice Mehnert,Bartosz Chmielowski, Gerri Lee,Paul Severson, Caro Unger, Xiaowei Guan, Richard Williams, Georgina Long

CANCER RESEARCH（2023）

引用 0|浏览4

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要